Stemedica

Maynard Howe

MAYNARD A. HOWE, PhD
CHIEF EXECUTIVE OFFICER AND VICE CHAIRMAN

Dr. Maynard Howe brings a richly diverse background to Stemedica. Along with his brother, Roger, he has launched five successful ventures in the medical device, software, testing and measurement, quality and consulting fields. Most recently, as Co-Chairman and CEO of Reliant Technologies, he led a team of scientists, engineers and physicians in developing, testing and launching the revolutionary medical laser for skin surgery known as Fraxel.

The Fraxel is an award winning medical laser technology that has resulted in defining a new category of science called fractional photothermolysis. This new science involves the role of lasers and the patients own stem cells in wound healing and dermatological and plastic surgery. The Fraxel laser, in conjunction with autologous and allogeneic stem cells is currently being used in new clinical study to treat scars, burn scars and diabetic ulcers. Reliant Technology has achieved a strong intellectual property position with over 20 patents issued and 40 pending applications. In addition, Reliant has secured 13 FDA clearances, and is well on its way to becoming the market leader with distribution in over 15 countries.

During his leadership tenure at Reliant, he lead the team responsible for securing funding from individual and institutional investors including: Three Arch Partners, Pinnacle Venture Partners, Meritech Capital Partners, Delphi Ventures and Comerica Bank. Reliant has recently filed an S1 with underwriter representation from investment bankers Piper Jaffrey, Banc of America Securities, Jeffries and Company and RBC Capital Markets.

Prior to Reliant he helped more than fifty Fortune 500 companies coordinate their company-wide quality and customer relationship initiatives. As a senior executive and co-founder of a leading customer and market research company, he was responsible for conducting extensive marketing and branding campaigns, market assessments and trend research in both business-to-business and business-to-consumer environments. Maynard is also co-founder and Chairman of BioPharma Scientific, a leading edge company specializing in the integration of pharmaceutical nanotechnology into the field of nutraceuticals. He has experience in setting up distribution and managing sales channels throughout North America, Europe and parts of Asia.

Maynard holds a Bachelor of Science Degree, Master of Science Degree and a Doctorate in Psychology. His ability to recruit world leaders and industry experts and create a culture of innovation and teamwork has contributed to the successes achieved in the businesses he has co-founded and those in which he has provided services as a board member and consultant.

Dr. Howe is the author and co-author of numerous articles and top selling business books. He is a nationally and internationally recognized speaker and lecturer. His benchmark book on quality, Quality on Trial, Bringing Customer Relationships into Focus, is in its second edition and has been published in several languages. Other books include a five part implementation manual series, Business to Business Marketing Management System, published by McGraw-Hill.

He is actively involved as a Board Member and Chairman of the Advanced Development Committee for Alliant International University. Dr. Howe continues to Chair Doctoral Dissertations in the Behavioral Science Field.